WHO trial to assess other antibodies, antiviral drugs after remdesivir doubt
WHO Director-General Tedros Adhanom Ghebreyesus said its Solidarity Trial would continue after it was launched in March in 500 hospitals in 30 countries to assess the efficacy of remdesivir and several other drugs in patients with COVID-19. The Solidarity Trial was at the centre of a dispute on Friday between the WHO and the U.S. … Read more